May 8, 2018 / 11:25 AM / 6 months ago

BRIEF-Genomedx Biosciences Announces Research Collaboration With Janssen Pharmaceuticals To Evaluate Decipher Classifier, Decipher Grid For Drug Development

May 8 (Reuters) - Johnson & Johnson:

* GENOMEDX BIOSCIENCES ANNOUNCES RESEARCH COLLABORATION WITH JANSSEN PHARMACEUTICALS TO EVALUATE THE DECIPHER® CLASSIFIER AND DECIPHER GRID® FOR DRUG DEVELOPMENT

* GENOMEDX BIOSCIENCES - UNDER DEAL, CO WILL TEST SAMPLES USING ITS GENOME-WIDE EXPRESSION ASSAY FROM MULTIPLE JANSSEN PROSTATE CANCER CLINICAL TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below